Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress
-Data Supports Deramiocel's Sustained Efficacy and Safety in Treating ...
| Ticker |
Sentiment |
Impact |
|
CAPR
|
Neutral
|
8 %
|
|
NPNKF
|
Somewhat Bullish
|
3 %
|
